The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active
- Celia Sequera
- Margherita Grattarola
- Floriane Cannet
- Aurélie Dobric
- Paula Michea Veloso
- Melissa Methia
- Sylvie Richelme
- Abdessamad El Kaoutari
- Paraskevi Kousteridou
- Delphine Debayle
- Lukas Kübler
- Sandro Nuciforo
- Yannick Boursier
- Mathieu Dupont
- Stefania Pizzimenti
- Giuseppina Barrera
- Jean-William Dupuy
- Frédéric Saltel
- Markus H. Heim
- Sophie Vasseur
- Xavier Adhoute
- Fabienne Guillaumond
- Jean-Paul Borg
- Christian Morel
- Flavio Maina
2025-08-25